An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Top results in this bookTable of Contents
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT.
McAuley DF, Laffey JG, O’Kane CM, et al.
Southampton (UK): NIHR Journals Library; 2018 Jan. (Efficacy and Mechanism Evaluation, No. 5.1.)
Therapeutics Letter.
Perry T, editor.
Vancouver (BC): Therapeutic Initiatives; 1994-.
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R, McFadden E, McLellan J, et al.
Southampton (UK): NIHR Journals Library; 2015 Dec. (Health Technology Assessment, No. 19.100.)
Screening for Lipid Disorders in Children and Adolescents: An Evidence Update for the U.S. Preventive Services Task Force [Internet].
Guirguis-Blake JM, Evans CV, Coppola EL, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jul. (Evidence Synthesis, No. 229.)
Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs.
Shankar-Hari M, Santhakumaran S, Prevost AT, et al.
Southampton (UK): NIHR Journals Library; 2021 Jul. (Efficacy and Mechanism Evaluation, No. 8.10.)
The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials.
van Staa TP, Dyson L, McCann G, et al.
Southampton (UK): NIHR Journals Library; 2014 Jul. (Health Technology Assessment, No. 18.43.)
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].
Patnode CD, Perdue LA, Rossom RC, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. (Evidence Synthesis, No. 189.)
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Elucigene FH20 and LIPOchip for the Diagnosis of Familial Hypercholesterolaemia: A Systematic Review and Economic Evaluation.
Sharma P, Boyers D, Boachie C, et al.
Southampton (UK): NIHR Journals Library; 2012 Mar. (Health Technology Assessment, No. 16.17.)
Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia [Internet].
Kane RL, Butler M, Fink HA, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Mar. (Comparative Effectiveness Reviews, No. 188.)
Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
Lozano P, Henrikson NB, Dunn J, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. (Evidence Syntheses, No. 141.)
Evidence review for statins: efficacy and adverse effects: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review C.
London: National Institute for Health and Care Excellence (NICE); 2023 May. (NICE Guideline, No. 238.)
Medical Genetics Summaries [Internet].
Pratt VM, Scott SA, Pirmohamed M, et al., editors.
Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
Description and Analysis of the VA National Formulary.
Institute of Medicine (US) VA Pharmacy Formulary Analysis Committee; Blumenthal D, Herdman R, editors.
Washington (DC): National Academies Press (US); 2000.
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022: Issue Brief [Internet].
Feyman Y, Sayed B, Finegold K, et al.
Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2024 Mar 7.
Evidence reviews for the investigation, management and follow-up of glioma: Brain tumours (primary) and brain metastases in adults: Evidence Report A.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Jul. (NICE Guideline, No. 99.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on